Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The goal of this pilot study is to establish the feasibility and initial efficacy of the
combination of phentermine and topiramate for adolescents and young adults who require
additional risk reduction after bariatric surgery. This study will use a randomized,
placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of
phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after
bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who
remain severely obese (n=10 total).
Phase:
Phase 2
Details
Lead Sponsor:
Jaime Moore, MD MPH
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) University of Colorado- Clinical and Translational Sciences Institute University of Colorado- Nutrition Obesity Research Center